Drug common name | EDICOTINIB |
INN | edicotinib |
Description | Edicotinib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against macrophage colony-stimulating factor 1 receptor. In addition, it is known to target receptor-type tyrosine-protein kinase FLT3 and mast/stem cell growth factor receptor Kit. |
Classification | Small molecule |
Drug class | tyrosine kinase inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC1(C)CC=C(c2nc(C3CC(C)(C)OC(C)(C)C3)ccc2NC(=O)c2nc(C#N)c[nH]2)CC1 |
PDB | — |
CAS-ID | 1142363-52-7 |
RxCUI | — |
ChEMBL ID | CHEMBL3674570 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 3NU609VYNF (ChemIDplus, GSRS) |